Aug 13,2024

Headspace Releases Free Mental Health Resources For Those Navigating Fertility Challenges in Partnership with Spring Fertility

Headspace has partnered with Spring Fertility to release "Support For Your Fertility Journey," a new collection of free mental health resources aimed at those facing challenges with conception. This initiative includes guided meditations, mindfulness exercises, and a video series designed to address the emotional and mental strain of fertility struggles. With many people experiencing heightened anxiety and depression during fertility journeys, especially in light of recent legal changes affecting reproductive rights, the collection offers tools for managing isolation, grief, and uncertainty. Additionally, Headspace is supporting IVF costs through Spring Fertility's grant program and collaborating with Rescripted to further support women’s health.

COLLABORATION PARTNERSHIP

#product & service

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Sep 17,2024

Q&A: Headspace on reproductive rights in an election cycle

Headspace, a digital mental health company, has partnered with Spring Fertility to launch "Support For Your Fertility Journey," a collection of meditations, mindfulness exercises, and conversations designed to help individuals through their fertility challenges. The content addresses grief, isolation, and self-care during procedures like IVF and miscarriage recovery. Additionally, Headspace is helping fund one IVF cycle for individuals through Spring Fertility's grant program. Dr. Jenna Glover, Headspace's chief clinical officer, emphasized the importance of providing mental health support in fertility, given its widespread impact, and reaffirmed the company's stance on supporting reproductive rights amid political uncertainty.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Apr 23,2024

Curio Digital Therapeutics Inc. Announces the FDA Clearance of MamaLift Plus

Curio Digital Therapeutics announces the FDA clearance of MamaLift Plus, marking the first prescription digital therapeutic for postpartum depression (PPD). MamaLift Plus is an eight-week prescription digital therapeutic intended for patients 22 years and older, to be used under healthcare provider supervision. It offers neurobehavioral interventions including Cognitive Behavioral Therapy (CBT), Behavioral Activation Therapy (BAT), Interpersonal Therapy (IPT), and Dialectical Behavior Therapy (DBT). Clearance is based on the SuMMER study, a national, sham-controlled, pivotal randomized controlled trial (RCT), where MamaLift Plus demonstrated efficacy in improving symptoms of depression. The study achieved its primary endpoint with 86.3% of participants experiencing a clinically meaningful improvement.

REGULATORY FDA

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Oct 18,2023

Point32Health Announces Three Finalists in Second Annual Innovation Challenge

Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, has announced three finalists for its second annual Innovation Challenge this fall: Cognoa, based in Palo Alto, California, developed Canvas Dx, the first-and-only FDA-authorized autism diagnostic for children starting at 18 months; Curio Digital Therapeutics, based in Princeton, NJ, developer of Curio-I™ that is an AI-Analytics tool that predicts/stratifies pregnant women pre-delivery/third trimester at risk for depression; and finally Movn Health, based in Irvine, California, a leading telehealth provider. The Innovation Challenge is an opportunity for one or more of these companies to work with Point32Health on a pilot or program, funded by the insurer.

View Analyst & Ambassador Comments
Go to original news
Mar 22,2023

Axena Health Receives Positive Insurance Coverage Decision From Cigna Healthcare for Leva Pelvic Health System

Axena Health, a medical device company focused on women's health, has received positive insurance coverage from Cigna Healthcare for its Leva Pelvic Health System. Cigna now considers the Leva System a covered treatment for stress, urgency, and mixed urinary incontinence in women. The coverage decision comes after Axena Health raised $25 million in a Series A funding round and published a study demonstrating the long-term efficacy of the Leva System for female urinary incontinence. The coverage will allow more women to access the Leva System, a prescription digital therapeutic that guides users through pelvic floor muscle training to treat urinary incontinence

COLLABORATION PARTNERSHIP

#insurance

#pdt

View Analyst & Ambassador Comments
Go to original news
Aug 24,2020

One Drop Announces Nearly $100M Financing And Commitments By Bayer

One Drop, a leader in digital solutions for people living with diabetes and other chronic conditions, today announced a new agreement with Bayer to jointly develop digital health products for multiple therapeutic areas based on One Drop's predictive, preventative, personalized self-care platform. It has closed on a $34.7 million Series C financing led by Bayer as well as $64 million in development fees and potential commercial milestone payments.

COLLABORATION PARTNERSHIP

#r&d

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 19,2019

EIT Health announces challenge focused on women's health, digital therapeutics

This year EIT Health, an EU-backed healthcare collaboration network, announced that its 2020 Wild Card Health Challenge will be focused on women’s health and digital therapeutics. First launched in 2017, the program offers European companies a way to connect with various healthcare stakeholders. The winner of each of the categories will receive €2 ($2.22) million in funding.

View Analyst & Ambassador Comments
Go to original news
Jan 27,2022

Mobile Health Launches Fully Integrated DTx Suite to Further Simplify Health and Wellbeing for Employees

Mobile Health, the digital health and wellbeing solution that makes it easy for employers to build a culture of health, announced the launch of a fully integrated suite of digital therapeutics (DTx) solutions. Mobile Health’s DTx suite includes: Behavioral Health, Women’s Health, Musculoskeletal, Prediabetes. With Mobile Health’s Digital Therapeutics suite, members have AI-based communication and targeted incentives fully integrated into the digital health and wellbeing experience to guide each individual through their unique health journey. Individuals can also engage in Mobile Health’s library of Health and Wellbeing Challenges, including individual healthy habits, team wellbeing challenges, and peer-to-peer wellbeing challenges to best support their long-term behavior change and improved health.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 10,2022

Anthem Partners with Happify to Launch a New Digital Maternal Health Platform

Anthem and Happify Health are teaming up to help bridge the gap between the unique physical and mental health concerns women face. Anthem is collaborating with Happify Health to develop a Sequence focused on maternal health. Eligible members of Anthem’s affiliated health plans in select markets will have access to Happify Health’s online pregnancy community, where they can connect with mental health experts, obstetrics, and gynecology experts, dietitians, and other healthcare professionals, ask questions, and discuss their physical challenges, and develop meaningful connections with others dealing with similar health issues. Eligible members will also have access to Happify Health’s evidence-based digital therapeutics, including a new non-prescription digital therapeutic addressing mental health needs during pregnancy.

COLLABORATION PARTNERSHIP

#insurance

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 12,2021

Labcorp Extends Leadership in Women’s Health With Acquisition of Ovia Health

Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has acquired Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy and parenting. The transaction extends Labcorp’s position as a leading, go-to source for women’s health insights, opens new avenues for personalized care experiences and fosters better dialogue between health care providers and their patients.

COLLABORATION MERGERS & ACQUISITION

#product & service

#rpm

#telehealth

View Analyst & Ambassador Comments
Go to original news
Subscribe to WOMEN'S HEALTH